Facebook Twitter

PATENTS AWARDED TO UTAH INVENTORS INCLUDE HYPERTENSION GENE ANALYSIS

SHARE PATENTS AWARDED TO UTAH INVENTORS INCLUDE HYPERTENSION GENE ANALYSIS

Gene analysis to determine predisposition of a human to hypertension is the basis of one of the three medical patents issued to Utah inventors by the United States Patent Office. Three mechanical patents were also issued.

Copies of patents are available by number for $3.00 from Box 9, Patent and Trademark Office, Washington, DC 20231. Abstracts and classifications are available at the Marriott Library, University of Utah.- Walter M. Lewis, Provo. A manual, dual-purpose garden tool which can function as a self-cleaning weeder and as a self- cleaning cultivator. Filed May 2, 1994. Patent 5,373,903.

- Paul E. Pastusek, Salt Lake City. A cutting structure for use in a rotary drag bit for drilling subterranean Earth formations. Assigned to Baker Hughes In-cor-porated, Houston, Tex. Filed Mar. 10, 1993. Patent 5,343,908.

- Monte G. Nelson, American Fork. A holder for a wound collapsible tube. Filed Mar. 17, 1994. Patent 5,373,968.

- Lindsay B. Lloyd, West Jordan; Jon E. Beck; Tomasz J. Petelenz, both of Salt Lake City; Clay H. Holt, Riverton, and William F. Felman, West Valley City. An electrode for use in the iontophoretic delivery of an ionic drug. Assigned to Iomed, Inc., Salt Lake City. Filed Apr. 7, 1993, a continuation-in-part of application Jan. 23, 1991, and patent 5,087,242. Patent 5,374,241.

- Thomas D. Rosenberg, Salt Lake City. A method of forming a passageway in a first bone at a joint between two bones. Assigned to American Cyanamid Company, Wayne, N.J. Filed Aug. 17, 1992, a division of patent 5,139,520. Patent 5,374,269.

- Jean-Marc Lalouel, Salt Lake City; Xavier Jeunemaitre, Paris, France; Richard P. Lifton, Salt Lake City; Florant Soubrier, Paris France; Youri Kotelevtsev, Edinburgh, United Kingdom, and Pierre Corval, Paris, France. A method for determining the predisposition of a human to hypertension which comprises analyzing the DNA sequence of the angiotensinogen (AGT) gene for a mutation selected from the group T174M and M235T. Assigned to University of Utah Research Foundation. Salt Lake City and INSERM, France. Filed Sep. 30, 1992. Patent 5,374,525.